RHBDD1

Across TCGA pan-cancer cohorts, RHBDD1 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated RHBDD1 data layer compared with 26 for mass-spec protein and 5 for mutation status.

The strongest signal is observed in lung squamous cell carcinoma (LSCC), where higher RHBDD1 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated RHBDD1 expression acts as an unfavorable survival marker, although some lineages such as LUAD and PDAC show a favorable association.

LSCC, LUAD, and PDAC are the cancer types where RHBDD1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LSCC	OS	Median	II,III,IV	0.561	0.929	.001	27	view →
LUAD	DFS	Median	III,IV	0.690	0.305	.038	6	view →
PDAC	OS	Median	III,IV	0.957	0.631	.011	3	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

RHBDD1–LSCC (OS)

Open the LSCC breakdown →